LEADER 02242oas  2200937 a 450 
001 9910139891703321
005 20251114213013.0
011   $a2152-2669
035   $a(DE-599)ZDB2540998-0
035   $a(DE-599)3181629-0
035   $a(OCoLC)475047678
035   $a(CONSER)  2009207926
035   $a(CKB)1000000000808510
035   $a(EXLCZ)991000000000808510
100   $a20091207a20109999  uy         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aClinical lymphoma, myeloma & leukemia
210   $aDallas, TX $cCIG Media Group$d2010-
210 3 $aNew York, NY $cElsevier
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311 08$a2152-2650 
517 1 $aClinical lymphoma, myeloma and leukemia
531 0 $aClin. lymphoma myeloma leuk.
606   $aLymphomas$vPeriodicals
606   $aLeukemia$vPeriodicals
606   $aLymphoma
606   $aMultiple Myeloma
606   $aLeukemia$2fast$3(OCoLC)fst00996894
606   $aLymphomas$2fast$3(OCoLC)fst01004321
608   $aPeriodical.
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
615  0$aLymphomas
615  0$aLeukemia
615  2$aLymphoma.
615  2$aMultiple Myeloma.
615  7$aLeukemia.
615  7$aLymphomas.
676   $a616.99
712 02$aCancer Information Group
801  0$bDLC
801  1$bDLC
801  2$bHEBIS
801  2$bDLC
801  2$bUKMGB
801  2$bEUE
801  2$bTXA
801  2$bOCLCQ
801  2$bTEF
801  2$bOPELS
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCQ
801  2$bOCLCF
801  2$bUAB
801  2$bOCLCQ
801  2$bFQM
801  2$bAU@
801  2$bOCLCO
801  2$bWYU
801  2$bTKN
801  2$bW2U
801  2$bU3W
801  2$bNJT
801  2$bBWN
801  2$bCUS
801  2$bOCLCQ
801  2$bQGK
801  2$bOCLCO
801  2$bOCLCQ
801  2$bAUD
801  2$bOCLCL
906   $aJOURNAL
912   $a9910139891703321
996   $aClinical lymphoma, myeloma & leukemia$91892438
997   $aUNINA